1Weiss D, Kools JJ, Taylor WR. Angiotensin Ⅱ-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation, 2001, 103: 448-454.
2Li J, Hirose N, Kawamura M, et al. Antiatherogenetic effect of angiotensin converting enzyme inhibitor(benazepril) and angiotensin Ⅱ receptor antagonist(valsartan) in the cholesterol-fed rabbits. Atherosclerosis, 1999, 143: 315-326.
3Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic leision. J Clin Invest, 1996, 97: 1715-1722.
4Baeuerie PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol, 1994, 12: 141-179.
5Ritchie ME. Nuclear factor-κB selectively and markedly activated in humans with unstable angina pectoris. Circulation, 1998, 98: 1707-1713.
6Wilson SH, Caplice NM, Simari RD, et al. Activated nuclear factor-κB is present in the coronary vasculature in experimental hypercholes-terolemia. Atherosclerosis, 2000, 148: 23-30.
